Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr:41:77-84.
doi: 10.1016/j.coviro.2020.05.007. Epub 2020 Jun 29.

Rapid diagnostic tests to address challenges for global measles surveillance

David W Brown  1 , Lenesha Warrener  2 , Heather M Scobie  3 , Morgane Donadel  3 , Diane Waku-Kouomou  4 , Mick N Mulders  5 , Paul A Rota  6
Affiliations
Review

Rapid diagnostic tests to address challenges for global measles surveillance

David W Brown et al. Curr Opin Virol. 2020 Apr.

Abstract

Recently, a lateral flow rapid diagnostic test (RDT) with good accuracy has been described. This test enables measles specific IgM antibody detection in serum, capillary blood and oral fluid. RDTs have the potential to transform measles surveillance by allowing real-time case confirmation outside of central/regional laboratories and by facilitating a timely public health response. Measles virus genes can also be amplified and sequenced consistently from dried IgM-positive RDTs stored outside of cold chain, which will enable more complete virologic surveillance. Critical questions remain regarding operational use of RDTs as part of global measles surveillance. Projects to evaluate RDT use as part of national surveillance programs and to commercialize the RDT are underway.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement

Nothing declared.

Figures

Figure 1
Figure 1
Diversity of potential settings and implications for measles rapid diagnostic test (RDT) use.
Figure 2
Figure 2
Circulation of measles virus genotypes globally reported through virologic surveillance, 1970–2019. Figure shows year of first and last detection of measles wild-type virus genotypes. The first and last years of documented circulation reported to the MeaNS database (or GenBank before 2005) for all 24 measles virus genotypes are shown. First year detection determined from earliest reported reference strain and does not necessarily indicate first year of circulation. The four currently circulating genotypes (detected in 2019) are indicated in red (B3, D4, D8, H1). Measles vaccines were derived from genotype A which is not shown.
See this image and copyright information in PMC

References

    1. World Health Organization: Measles vaccines: WHO position paper - April 2017. Wkly Epidemiol Rec 2017, 92:205–227.
    1. Patel MK, Dumolard L, Nedelec Y, Sodha SV, Steulet C, Gacic-Dobo M, Kretsinger K, McFarland J, Rota PA, Goodson JL: Progress toward regional measles elimination - worldwide, 2000–2018. MMWR Morb Mortal Wkly Rep 2019, 68:1105–1111 - PMC - PubMed

    2. In this most recent of an annual series, the authors summarize progress towards global measles elimination by WHO region in terms of routine immunization coverage, campaign coverage, reported incidence and estimated measles mortality. The article highlights the remaining gaps in immunization programs and surveillance in order to achieve regional measles elimination goals.

    1. Durrheim DN, Crowcroft NS, Blumberg LH: Is the global measles resurgence a “public health emergency of international concern”? Int J Infect Dis 2019, 83:95–97. - PubMed
    1. Thornton J: Measles cases in Europe tripled from 2017 to 2018. BMJ 2019, 364:l634. - PubMed
    1. World Health Organization: Vaccine Preventable Diseases Surveillance Standards: Measles chapter. 2018. [https://www.who.int/immunization/monitoring_surveillance/burden/vpd/stan...].

Publication types